These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18054475)

  • 1. Rationale for adjuvant fatty acid therapy to prevent radiotherapy failure and tumor recurrence during early laryngeal squamous cell carcinoma.
    Louw L; Claassen J
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):21-6. PubMed ID: 18054475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-induced recurrent laryngeal papillomatosis: rationale for adjuvant fatty acid therapy.
    Louw L; Claassen A
    Asia Pac J Clin Nutr; 2008; 17(2):187-93. PubMed ID: 18586635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV-induced recurrent laryngeal papillomatosis: fatty acid role-players.
    Louw L; Seedat R; Claassen A
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():208-11. PubMed ID: 18296339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
    Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
    J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment.
    Ogawa T; Shiga K; Tateda M; Saijo S; Suzuki T; Sasano H; Miyagi T; Kobayashi T
    Oncol Rep; 2003; 10(5):1461-6. PubMed ID: 12883724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
    Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
    J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.
    Marioni G; Staffieri A; Lionello M; Tealdo G; Staffieri C; Giacomelli L; Friso ML; Stramare R; Ottaviano G; Blandamura S
    J Oral Pathol Med; 2013 Apr; 42(4):339-44. PubMed ID: 23126236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy.
    Jiang H; Yang BB
    Acta Otolaryngol; 2009 Jan; 129(1):101-7. PubMed ID: 18607952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
    Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-induced recurrent laryngeal papillomatosis: dietary fatty acid and micronutrient intakes.
    Louw L; Walsh C
    Asia Pac J Clin Nutr; 2008; 17(2):352-7. PubMed ID: 18586658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells.
    Zhuang ZH; Tsao SW; Deng W; Wang JD; Xia HH; He H; Feng HC; Wang LD; Gu Q; Lam SK; Lin MC; Kung HF; Wong BC
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1613-20. PubMed ID: 18717758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
    Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
    Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioresistant laryngeal cancer: beyond the TNM stage.
    Nix PA; Greenman J; Cawkwell L; Stafford N
    Clin Otolaryngol Allied Sci; 2004 Apr; 29(2):105-14. PubMed ID: 15113291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR expression and prognosis in elderly patients with laryngeal carcinoma: uni- and multivariate analyses.
    Marioni G; Staffieri A; Lora L; Fermo S; Giacomelli L; La Torre FB; Favaretto N; Valentini E; Manzato E; Blandamura S
    Oral Oncol; 2012 Jun; 48(6):530-4. PubMed ID: 22285859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maspin expression and anti-apoptotic pathway regulation by bcl2 in laryngeal cancer.
    Lovato A; Franz L; Carraro V; Bandolin L; Contro G; Ottaviano G; de Filippis C; Blandamura S; Alessandrini L; Marioni G
    Ann Diagn Pathol; 2020 Apr; 45():151471. PubMed ID: 31986422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of cyclooxygenase 2 and Bcl-2 for cervical lymph node metastasis in mucoepidermoid carcinoma.
    Zyada MM; Grawish ME; Elsabaa HM
    Ann Diagn Pathol; 2009 Oct; 13(5):313-21. PubMed ID: 19751908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Analysis of BCL2 Expression in Laryngeal Squamous Cell Carcinoma.
    Chrysovergis A; Papanikolaou VS; Tsiambas E; Ragos V; Peschos D; Kyrodimos E
    Anticancer Res; 2019 Mar; 39(3):1253-1257. PubMed ID: 30842155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does vocal cord fixation preclude nonsurgical management of laryngeal cancer?
    Solares CA; Wood B; Rodriguez CP; Lorenz RR; Scharpf J; Saxton J; Rybicki LA; Strome M; Esclamado R; Lavertu P; Adelstein DJ
    Laryngoscope; 2009 Jun; 119(6):1130-4. PubMed ID: 19358250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.